bluebird bio Inc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares bluebird bio Inc with three other
companies in this sector in the United States:
India Globalization Capital, Inc.
sales of $6.37 million
of which 98%
Crispr Therapeutics AG
Clinuvel Pharmaceuticals Limited
of which 100%
bluebird bio Inc reported sales of $6.16 million
December of 2016.
decrease of 56.3%
versus 2015, when the company's sales were $14.08 million.